glp-1 drugs and thyroid cancer agonist like Ozempic do not increase risk Study: GLP-1 drugs don't increase

Although hair loss and and GLP-1 medications are linked, it's not the medication that directly causes the hair loss

Clinically relevant weight loss is achieved independently of early weight loss response to once-weekly subcutaneous semaglutide 2.4 MG (STEP 4)

The primary advantages of GLP-1RAs lie in glucose reduction, cardiorenal benefits, and amelioration of metabolic syndrome, all of which are substantiated by a plethora of evidence-based studies [1,2,3,4]

GLP-1 and Blood Pressure: What the Evidence Shows GLP-1 receptor agonists, primarily licensed for type 2 diabetes and obesity management, have demonstrated modest blood pressure-lowering effects in clinical trials